Načítá se...

Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood & Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)

Based on promising pilot data, a Phase II tandem autologous hematopoietic stem cell transplant (AHSCT) trial for relapsed/refractory Hodgkin Lymphoma (HL) was performed in the US intergroup setting to determine if long-term progression-free survival (PFS) could be improved. Patients were enrolled af...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Smith, Eileen P., Li, Hongli, Friedberg, Jonathan W., Constine, Louis S., Rimsza, Lisa M., Cook, James R., Laport, Ginna G., Popplewell, Leslie L., Holmberg, Leona A., Smith, Sonali M., LeBlanc, Michael, Forman, Stephen J., Fisher, Richard I., Stiff, Patrick J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5965270/
https://ncbi.nlm.nih.gov/pubmed/29289757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.12.798
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!